Priveterra Acquisition Corp. Contracts & Agreements

Senior Secured Convertible Note, dated April 12, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on April 17, 2024)

Third Amendment to License and Supply Agreement, dated April 24, 2023, by and between Daewoong Pharmaceutical Co (Filed With SEC on April 2, 2024)

Second Amendment to the License and Supply Agreement, dated as of January 8, 2023, by and between AEON Biopharma, Inc. and Daewoong Pharmaceutical Co., Ltd (Filed With SEC on April 2, 2024)

AEON Biopharma, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on April 2, 2024)

Consulting Agreement, by and between AEON Biopharma, Inc. and Eric Carter, M.D., dated January 30, 2020, and amended on January 30 2020 and September 30, 2020 (Filed With SEC on March 29, 2024)

Senior Secured Convertible Note, dated March 24, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 28, 2024)

Security Agreement, dated March 19, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)

Form of Senior Secured Convertible Note, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)

Subscription Agreement, dated March 19, 2024, by and between AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)

Guaranty, dated March 19, 2024, by and between Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)

Fourth Amendment to License and Supply Agreement, dated March 19, 2024, by and between AEON Biopharma, Inc. and Daewoong Pharmaceutical Co., LTD (Filed With SEC on March 19, 2024)

Termination Agreement, dated March 18, 2024, by and between AEON Biopharma, Inc. and ACM ARRT J LLC (Filed With SEC on March 19, 2024)

Termination Agreement, dated March 18, 2024, by and between AEON Biopharma, Inc. and Polar Multi-Strategy Fund (Filed With SEC on March 19, 2024)

Sponsor Support Agreement, dated as of December 12, 2022, by and among Priveterra Sponsor, LLC, Priveterra Acquisition Corp., and the other parties thereto (Filed With SEC on November 24, 2023)

Note Subscription Agreement, dated as of June 27, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, and Alphaeon 1, LLC (Filed With SEC on July 27, 2023)

AEON Biopharma, Inc. Amended and Restated 2019 Incentive Award Plan (incorporated by reference to Exhibit 10.1 to the Form S-4/A filed by Priveterra Acquisition Corp. with the SEC... (Filed With SEC on July 27, 2023)

Amended and Restated Employment Agreement, by and between AEON Biopharma, Inc. and Marc Forth (Filed With SEC on July 27, 2023)

Employment Agreement, by and between AEON Biopharma, Inc. and Chad Oh (Filed With SEC on July 27, 2023)

Employment Agreement, by and between AEON Biopharma, Inc. and Alex Wilson (Filed With SEC on July 27, 2023)

Amended and Restated Registration Rights Agreement, dated as of July 21, 2023, by and between AEON Biopharma, Inc. and the stockholders party thereto (Filed With SEC on July 27, 2023)

Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)

Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)

FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)

FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)

New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)

New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)

Note Subscription Agreement, dated as of June 27, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, and Daewoong Co., Ltd (Filed With SEC on July 27, 2023)

Amendment No. 1 to Note Subscription Agreement, dated June 23, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and Alphaeon 1, LLC (Filed With SEC on July 27, 2023)

Form of Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and ACM ARRT J LLC (Filed With SEC on June 30, 2023)

Form of New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)

Form of FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)

Form of Note Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)

Form of Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and Polar Multi-Strategy Master Fund (Filed With SEC on June 30, 2023)

Promissory Note, dated as of April 28, 2023, by and among Privaterra Acquisition Corp. and Priveterra Sponsor, LLC (Filed With SEC on May 1, 2023)

Amendment No. 1 to Sponsor Support Agreement, dated as of April 27, 2023, by and among Priveterra Acquisition Corp., Priveterra Sponsor, LLC, Priveterra Merger Sub, Inc., AEON... (Filed With SEC on May 1, 2023)

Amendment No. 1 to Business Combination Agreement, dated as of April 27, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and Priveterra Merger Sub, Inc (Filed With SEC on May 1, 2023)

Form of Letter Agreement (Filed With SEC on January 11, 2023)

Amendment to Settlement and License Agreement dated May 5, 2022, by and between AEON Biopharma, Inc. and Medytox, Inc (Filed With SEC on December 27, 2022)

Settlement and License Agreement dated June 21, 2021, by and between AEON Biopharma, Inc. and Medytox, Inc (Filed With SEC on December 27, 2022)

Amendment to License and Supply Agreement, dated as of July 29, 2022, by and between Daewoong Pharmaceutical Co., Ltd. and AEON Biopharma, Inc (Filed With SEC on December 27, 2022)

License and Supply Agreement, dated as of December 20, 2019, by and between Daewoong Pharmaceutical Co., Ltd. and AEON Biopharma, Inc (Filed With SEC on December 27, 2022)

Offer Letter, by and between AEON Biopharma, Inc. and Chad Oh (Filed With SEC on December 27, 2022)

Employment Agreement, by and between AEON Biopharma, Inc. and Chris Carr (Filed With SEC on December 27, 2022)

Employment Agreement, by and between AEON Biopharma, Inc. and Marc Forth (Filed With SEC on December 27, 2022)

Convertible Promissory Note, dated as of February 15, 2021, issued to Priveterra Sponsor, LLC (Filed With SEC on February 18, 2021)

Investment Management Trust Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on February 12, 2021)

Underwriting Agreement, dated February 8, 2021, by and among the Company and Wells Fargo Securities, LLC and Guggenheim Securities, LLC, as representatives of the several... (Filed With SEC on February 12, 2021)

Warrant Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on February 12, 2021)

Letter Agreement, dated February 8, 2021, by and among the Company, its executive officers, its directors and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)

Registration Rights Agreement, dated February 8, 2021, by and among the Company, Priveterra Sponsor, LLC and the other holders party thereto (Filed With SEC on February 12, 2021)

Private Placement Warrants Purchase Agreement, dated February 8, 2021, by and among the Company and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)

Administrative Services Agreement, dated February 8, 2021, by and between the Company and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)

Form of Registration Rights Agreement between the Registrant and the Holders signatory thereto (Filed With SEC on January 29, 2021)

Form of Administrative Services Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 29, 2021)

Form of Indemnity Agreement (Filed With SEC on January 29, 2021)

Form of Private Placement Warrants Purchase Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 29, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)

Form of Letter Agreement among the Registrant, Priveterra Sponsor, LLC and each of the executive officers and directors of the Registrant (Filed With SEC on January 29, 2021)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)

Specimen Warrant Certificate (Filed With SEC on January 29, 2021)

Specimen Class A Common Stock Certificate (Filed With SEC on January 29, 2021)

Specimen Unit Certificate (Filed With SEC on January 29, 2021)

Form of Underwriting Agreement (Filed With SEC on January 29, 2021)

Promissory Note issued to Priveterra Sponsor, LLC (Filed With SEC on January 21, 2021)

Securities Subscription Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 21, 2021)

Category

Industry

Companies

Contracts

Priveterra Acquisition Corp. Contracts & Agreements